Hinge Health, Inc.
HNGE
$40.91
-$1.20-2.85%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.71% | 10.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.71% | 10.87% | |||
| Cost of Revenue | -5.08% | -30.83% | |||
| Gross Profit | 14.21% | 27.96% | |||
| SG&A Expenses | -16.29% | -74.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 267.50% | -95.52% | |||
| Total Operating Expenses | -10.50% | -77.73% | |||
| Operating Income | 547.33% | 98.95% | |||
| Income Before Tax | 2,066.85% | 99.76% | |||
| Income Tax Expenses | -40.78% | 162.80% | |||
| Earnings from Continuing Operations | 1,840.51% | 99.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,840.51% | 99.73% | |||
| EBIT | 547.33% | 98.95% | |||
| EBITDA | 602.42% | 99.05% | |||
| EPS Basic | 1,824.79% | 99.82% | |||
| Normalized Basic EPS | 2,047.69% | 99.84% | |||
| EPS Diluted | 1,723.08% | 99.82% | |||
| Normalized Diluted EPS | 1,932.31% | 99.84% | |||
| Average Basic Shares Outstanding | 0.84% | 79.50% | |||
| Average Diluted Shares Outstanding | 7.20% | 79.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||